Overview
Lobbying Costs
150,000€
Financial year: Jan 2016 - Dec 2016
Lobbyists (Full time equivalent)
5.25 Fte (8)
Lobbyists with EP accreditation
0
High-level Commission meetings
1
Lobbying Costs over the years
-
Info
Newron Pharmaceuticals
EU Transparency Register
641179826954-41 First registered on 27 Apr 2017
Goals / Remit
Newron is becoming a leader in the development of innovative therapies for Central Nervous System (CNS) disorders and pain, and is committed to improving the quality of life of patients. Our team have built a well-balanced pipeline that embodies highly developed novel therapies for rare CNS diseases, specifically, innovative compounds at different stages of development.
Main EU files targeted
Newron Pharmaceuticals SpA will be visiting Brussels to have meeting with various EU Institutions and agencies and intend to apply under Horizon 2020 Funding.
Address
Head Office
Via Ludovico Ariosto, 21
Bresso (MI) 20091
ITALY -
People
Total lobbyists declared
8
Employment time Lobbyists 75% 5 50% 3 Lobbyists (Full time equivalent)
5.25
Lobbyists with EP accreditation
No lobbyists with EP accreditations
Complementary Information
None declared
Person in charge of EU relations
Mr Marco Caremi (Executive Vice President Business Development)
Person with legal responsibility
Mr Marco Caremi (Executive Vice President Business Development)
-
Categories
Category
II - In-house lobbyists and trade/business/professional associations
Subcategory
Companies & groups
-
Networking
Affiliation
None declared
Member organisations
http://www.newron.com/ENG/Default.aspx?PAG=78
-
Financial Data
Closed financial year
Jan 2016 - Dec 2016
Lobbying costs for closed financial year
150,000€
Other financial info
None declared
-
EU Structures
Groups (European Commission)
None
ACC
None
Groups (European Parliament)
None
Communication activities
None
Other activities
None declared
Meetings
Meetings
1 meetings found. Download meetings
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.
1 July 2024: We have noted that some meetings are appearing in duplicate, ie. some meetings seem to be listed twice. This seems to be because the Commission changes some element of a meeting data after the meeting has first been listed, which causes LobbyFacts to register it as a new meeting. We are investigating further.
-
Date 11 May 2017 Location Brussels Subject HTA Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Annika Nowak (Cabinet member)